The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C

被引：14
|
作者：
Adinolfi, Luigi Elio [1 ]
Rinaldi, Luca [1 ]
Marrone, Aldo [1 ]
Giordano, Mauro [1 ]
机构：
[1] Univ Campania L Vanvitelli, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2018年 / 16卷 / 08期
关键词：
DAAs; chronic hepatitis C; insulin resistance; type 2 diabetes mellitus; GLYCEMIC CONTROL; IMPROVEMENT; INFECTION; HCV;
D O I：
10.1080/14787210.2018.1505500
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：595 / 597
页数：3
相关论文
共 50 条
  • [21] Impact of Substance Use Disorder on the Rate of Sustained Virological Response in Veterans With Chronic Hepatitis C Treated With Direct-Acting Antivirals
    Ottman, Andreina A.
    Townsend, Mary L.
    Hashem, Mohamed G.
    Britt, Rachel B.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (06) : 581 - 587
  • [22] Predictors of hepatocellular carcinoma occurrence in men with chronic hepatitis C who achieved sustained virological response with direct-acting antivirals
    Abu Shawish, W.
    Gan, K. M. L.
    Pradhan, S.
    Zhang, G.
    Connelly, C.
    Scagliotta, M.
    Ayonrinde, O.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 73 - 74
  • [23] Direct-acting antivirals for chronic hepatitis C
    Jakobsen, Janus C.
    Nielsen, Emil Eik
    Feinberg, Joshua
    Katakam, Kiran Kumar
    Fobian, Kristina
    Hauser, Goran
    Poropat, Goran
    Djurisic, Snezana
    Weiss, Karl Heinz
    Bjelakovic, Milica
    Bjelakovic, Goran
    Klingenberg, Sarah Louise
    Liu, Jian Ping
    Nikolova, Dimitrinka
    Koretz, Ronald L.
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06):
  • [24] Direct-acting antivirals for chronic hepatitis C
    Jakobsen, Janus C.
    Nielsen, Emil Eik
    Feinberg, Joshua
    Katakam, Kiran Kumar
    Fobian, Kristina
    Hauser, Goran
    Poropat, Goran
    Djurisic, Snezana
    Weiss, Karl Heinz
    Bjelakovic, Milica
    Bjelakovic, Goran
    Klingenberg, Sarah Louise
    Liu, Jian Ping
    Nikolova, Dimitrinka
    Koretz, Ronald L.
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [25] Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response
    Luan, Chih-Hsuan
    Su, Pin-Shuo
    Chu, Chi-Jen
    Lin, Chung-Chi
    Su, Chien-Wei
    Lee, Shou-Dong
    Wang, Yuan-Jen
    Lee, Fa-Yauh
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (09) : 795 - 805
  • [26] Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment
    Elhelbawy, Mostafa
    Abdel-Razek, Wael
    Alsebaey, Ayman
    Hashim, Mohamed
    Elshenawy, Hassan
    Waked, Imam
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 16 - 23
  • [27] Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
    Jimenez-Perez, Miguel
    Gonzalez-Grande, Rocio
    Espana Contreras, Pilar
    Pinazo Martinez, Isabel
    de la Cruz Lombardo, Jesus
    Olmedo Martin, Raul
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (29) : 6573 - 6581
  • [28] Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
    Miguel Jiménez-Pérez
    Rocío González-Grande
    Pilar Espa?a Contreras
    Isabel Pinazo Martínez
    Jesús de la Cruz Lombardo
    Raúl Olmedo Martín
    World Journal of Gastroenterology, 2016, 22 (29) : 6573 - 6581
  • [29] Triglyceride-rich lipoproteins and insulin resistance in patients with chronic hepatitis C receiving direct-acting antivirals
    Casas-Deza, Diego
    Espina, Silvia
    Martinez-Sapina, Ana
    del Moral-Bergos, Raquel
    Garcia-Sobreviela, Maria Pilar
    Lopez-Yus, Marta
    Calmarza, Pilar
    Bernal-Monterde, Vanesa
    Arbones-Mainar, Jose M.
    ATHEROSCLEROSIS, 2023, 375 : 59 - 66
  • [30] Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C and STAGE-3 LIVER Fibrosis after Sustained Virological Response with Direct-Acting Antivirals
    Sanchez Azofra, Maria
    Luisa Montes, Maria
    Fernandez-Rodriguez, Conrado M.
    Moreno, Victoria
    Poza, Joaquin
    Martin-Carbonero, Luz
    Ruiz Fernandez, Gloria
    Valencia, Eulalia
    Jaquotot, Marta
    Ignacio Bernardino, Jose
    Marin, Eva
    Perez-Valero, Ignacio
    De Maria, Pedro
    Gonzalez, Juan
    Tavecchia, Mariana
    Romero, Miriam
    Garcia Sanchez, Araceli
    Carlos Erdozain, Jose
    Gutierrez Garcia, Maria Luisa
    Suarez, Cristina
    Ferrer, Juan
    Mora, Pedro
    Javier Garcia-Samaniego, Francisco
    Olveiral, Antonio
    Castillo, Pilar
    HEPATOLOGY, 2018, 68 : 865A - 866A
12345